Thoracic myelopathy is relatively uncommon because few degenerative changes occur as a result of the restricted range of motion surrounding the rib cage. Disorders that can cause thoracic myelopathy include ossification of the posterior longitudinal ligament (OPLL), ossification of the ligamentum flavum (OLF), spinal tumor, spinal cord tumor, trauma, infection, thoracic disk disease, and spinal cord herniation (SCH).^[@R1][@R2][@R3]^ These disorders all generally require surgical intervention because of their progressive nature and poor response to conservative therapy.^[@R4],[@R5]^

Thoracic myelopathy can cause symptoms such as leg pain, girdle pain, back pain, low back pain, motor and sensory deficit, and bowel bladder dysfunction. However, these symptoms mimic those of cervical or lumbar spinal disorders, and thus, thoracic myelopathy is often overlooked in a search for a cervical or lumbar etiology, which can result in delayed treatment.^[@R6],[@R7]^ Misdiagnosis can also lead to a prolonged preoperative disease duration, which can result in myelopathy and cause irreversible neurologic damage.^[@R2]^ However, the characteristics of thoracic myelopathy have not been adequately addressed because of the low prevalence and the small number of patients treated surgically.^[@R2]^

Knowledge of the symptoms of thoracic myelopathy is important for early diagnosis and treatment. Therefore, in this study, we examined symptoms and physical examination findings associated with diseases that cause myelopathy at each level of the thoracic spine, with the goal of identifying factors that are associated with these diseases.

Methods {#s1}
=======

A retrospective study was performed in 300 consecutive cases of thoracic disorders with myelopathy treated at our department from 2000 to 2015 (Table [1](#T1){ref-type="table"}). The study was approved by the institutional review board of our university.

###### 

Summary of Demographic Data in 300 Patients With Thoracic Myelopathy

  ------------------------- -----------------------
  Sex                       
   Male                     166
   Female                   134
  Age (yr)                  54.5 ± 16.2 (13-86)
  Disease duration (mo)     17.0 ± 32.5 (0.5-120)
  Preoperative JOA score    5.7 ± 2.8 (0-9)
  Postoperative JOA score   7.5 ± 2.2 (0-11)
  JOA recovery rate         38.2 ± 51.6 (−75-100)
  ------------------------- -----------------------

JOA = Japanese Orthopaedic Association

Data are shown as mean ± SD with range in parentheses.

The severity of myelopathy before and after surgery was evaluated using the Japanese Orthopaedic Association (JOA) score for thoracic myelopathy (total of 11 points), which was derived from the JOA score for cervical myelopathy by eliminating the motor and sensory scores for the upper extremities.^[@R8],[@R9]^ Postoperative improvement of symptoms was evaluated using the % recovery of the JOA score and the Hirabayashi method (\[postoperative JOA score − preoperative JOA score\]/\[11 − preoperative JOA score\] × 100%), with a recovery rate of 100% indicating the best postoperative improvement.

Girdle pain, back pain, low back pain, leg numbness, leg pain, gait disturbance, leg paresis, and bowel bladder disturbance (BBD) as initial and preoperative symptoms; patellar tendon reflex (PTR), ankle tendon reflex (ATR), and ankle clonus as preoperative neurologic findings; MRI and CT findings; and surgical procedure, intraoperative findings, and postoperative recovery were investigated. T1-4 was defined as the upper level, T5-8 as the middle level, and T9-12 as the lower level. The follow-up period was a minimum of 1 year.

Data were analyzed using SPSS ver. 22 (IBM SPSS Statistics 19.0; IBM). Data are presented as mean ± SD. Radiographic parameters and clinical data from 2 groups were compared by the Student *t*-test. Multivariate logistic regression analyses were used to calculate the odds ratios (ORs) and 95% confidence interval (CI) to identify factors associated with disease or affected level. *P* \< 0.05 was considered significant.

Results {#s2}
=======

Clinical Manifestation {#s2-1}
----------------------

Sex, mean age at surgery, disease duration, follow-up period, preoperative and postoperative JOA score, JOA recovery rate, disease distribution, affected level, initial and preoperative symptoms, and neurologic findings are described in Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}. The 300 patients (166 men and 134 women) had an age range of 13 to 86 years (mean age, 54.7 years). The mean disease duration from onset to surgery was 17.0 months (range, 0.5 to 120 months). The diseases included OLF (n = 48), OPLL (n = 30), OPLL with OLF (n = 27), intradural extramedullary tumor (n = 98), intramedullary spinal cord tumor (IMSCT) (n = 64), vertebral tumor (VT) (n = 17), SCH (n = 7), vertebral fracture (VF) (n = 4), and thoracic disk herniation (TDH) (n = 5). The number of symptoms just before surgery was higher than the number of initial symptoms. Moreover, the rate of myelopathy such as leg numbness, gait disturbance, leg paresis, and BBD notably increased more than that of girdle pain, back pain, and low back pain (Table [2](#T2){ref-type="table"}). There was a significant improvement in the mean JOA score from 5.7 preoperatively to 7.5 at the last follow-up postoperatively (*P* \< 0.01), and this change gave a mean recovery rate of 38.2% (Table [1](#T1){ref-type="table"}).

###### 

Clinical Features of Patients With Thoracic Myelopathy

  ------------------------------- -------------------------
  Disease                         
   OLF                            48 (16%)
   OPLL                           30 (10%)
   OPLL + OLF                     27 (9%)
   IET                            98 (32.7%)
   IMSCT                          64 (21.3%)
   VT                             17 (5.7%)
   SCH                            7 (2.3%)
   VF                             4 (1.3%)
   TDH                            5 (1.7%)
  Affected level                  
   Upper                          68 (22.6%)
   Middle                         103 (34.2%)
   Lower                          129 (42.9%)
  Initial/preoperative symptoms   
   Girdle pain                    19 (6.3%)/22 (7.3%)
   Back pain                      49 (16.3%)/58 (19.3%)
   Low back pain                  66 (21.9%)/82 (27.2%)
   Leg numbness                   159 (52.8%)/242 (80.2%)
   Leg pain                       49 (16.3%)/66 (21.9%)
   Gait disturbance               78 (25.9%)/193 (64.1%)
   Leg paresis                    21 (7%)/102 (33.9%)
   BBD                            9 (3%)/27 (9%)
  Neurologic findings             
   PTR                            196 (65.1%)
   ATR                            179 (59.5%)
   Ankle clonus                   122 (40.5%)
  ------------------------------- -------------------------

ATR = ankle tendon reflex, BBD = bowel bladder disturbance, IET = intradural extramedullary tumor, IMSCT = intramedullary spinal cord tumor, OLF = ossification of the ligamentum flavum, OPLL = ossification of the posterior longitudinal ligament, PTR = patellar tendon reflex, SCH = spinal cord herniation, TDH = thoracic disk herniation, VF = vertebral fracture, VT = vertebral tumor

Disease and Affected Level {#s2-2}
--------------------------

Sex, age, and rates of hyper-PTR and hyper-ATR were similar among the disease groups. However, the disease duration tended to be longer for IMSCT and SCH and shorter for VT, VF, and TDH compared with other diseases. The preoperative JOA score was lower in OPLL + OLF and SCH. OLF occurred at a lower level, and OPLL and OPLL + OLF were found at a middle level most frequently. The JOA recovery rate was lower in OPLL, OPLL + OLF, and IMSCT (Table [3](#T3){ref-type="table"}). For the affected levels, sex, age, disease duration, and preoperative and postoperative JOA scores were similar, but hyper-PTR, hyper-ATR, and positive ankle clonus occurred less frequently at the lower level (Table [4](#T4){ref-type="table"}).

###### 

Patients\' Demographics for Each Disease

  Factor                          OLF                     OPLL                    OPLL + OLF              IET                     IMSCT                   VT                     SCH                   VF                    TDH
  ------------------------------- ----------------------- ----------------------- ----------------------- ----------------------- ----------------------- ---------------------- --------------------- --------------------- ---------------------
  n                               48                      30                      27                      98                      64                      17                     7                     4                     5
  Sex                                                                                                                                                                                                                        
   Male                           35 (72.9%)              17 (56.7%)              14 (51.9%)              51 (52.0%)              36 (56.3%)              9 (52.9%)              2 (28.6%)             1 (25.0%)             2 (40.0%)
   Female                         13 (27.1%)              13 (43.3%)              13 (48.1%)              47 (48.0%)              28 (43.8%)              8 (47.1%)              5 (71.4%)             3 (75.0%)             3 (60.0%)
  Mean age (years)                56.5 ± 15.6 yr          52.3 ± 14.8 yr          52.8 ± 10.4 yr          54.9 ± 16.4 yr          44.8 ± 16.4 yr          52.3 ± 18.5 yr         54.1 ± 9.4 yr         74.3 ± 6.4 yr         54.2 ± 12.6 yr
  Mean disease duration (mo)      17.4 ± 18.8 mo          10.0 ± 9.6 mo           17.4 ± 26.5 mo          19.0 ± 40.7 mo          21.3 ± 40.0 mo          7.1 ± 14.1 mo          24.4 ± 42.3 mo        5.0 ± 3.6 mo          4.4 ± 3.5 mo
  Preoperative JOA score          6.2 ± 2.5               4.8 ± 2.5               3.9 ± 2.4               6.4 ± 42.8              6.2 ± 2.6               4.1 ± 2.9              3.4 ± 1.5             5.3 ± 2.6             5.8 ± 3.9
  Postoperative JOA score         8.2 ± 1.9               6.8 ± 2.0               6.2 ± 1.9               8.1 ± 2.1               7.3 ± 2.4               6.8 ± 1.8              5.9 ± 2.0             7.3 ± 2.9             7.0 ± 3.5
  JOA recovery rate (%)           45.8 ± 21.6             35.5 ± 17.2             34.3 ± 18.7             42.1 ± 28.0             29.3 ± 33.0             36.5 ± 18.2            32.4 ± 18.5           47.2 ± 37.4           38.2 ± 35.3
  Affected level                                                                                                                                                                                                             
   Upper                          7 (14.6%)               8 (26.7%)               5 (18.5%)               24 (24.5%)              16 (25.0%)              7 (41.2%)              2 (28.6%)             0 (0.0%)              0 (0.0%)
   Middle                         3 (6.3%)                19 (63.3%)              18 (66.7%)              29 (29.6%)              16 (25.0%)              7 (41.2%)              5 (71.4%)             1 (25.0%)             3 (60.0%)
   Lower                          38 (79.2%)              3 (10.0%)               3 (11.1%)               45 (45.9%)              32 (50.0%)              3 (17.6%)              0 (0.0%)              3 (75.0%)             2 (40.0%)
  Initial/preoperative symptoms                                                                                                                                                                                              
   Girdle pain                    0 (0%)/0 (0%)           2 (6.7%)/2 (6.7%)       1 (3.7%)/4 (4.1%)       4 (4.1%)/2 (7.4%)       7 (10.9%)/8 (12.5%)     5 (29.4%)/6 (35.3%)    0 (0.0%)/0 (0.0%)     0 (0.0%)/0 (0.0%)     0 (0.0%)/0 (0.0%)
   Back pain                      0 (0%)/2 (4.2%)         3 (10.0%)/3 (10.2%)     3 (11.1%)/3 (11.1%)     17 (17.3%)/20 (20.4%)   16 (25.0%)/17 (26.6%)   7 (41.2%)/10 (58.8%)   0 (0.0%)/0 (0.0%)     2 (50.0%)/2 (50.0%)   0 (0.0%)/0 (0.0%)
   Low back pain                  8 (16.7%)/12 (25.0%)    4 (13.3%)/6 (20.0%)     2 (7.4%)/3 (11.1%)      29 (29.6%)/34 (34.7%)   16 (25.0%)/19 (29.7%)   3 (17.6%)/3 (17.6%)    1 (14.3%)/2 (28.6%)   2 (50.0%)/2 (50.0%)   2 (40.0%)/2 (40.0%)
   Leg numbness                   32 (66.7%)/33 (68.8%)   18 (60.0%)/23 (76.7%)   17 (63.0%)/21 (77.8%)   45 (45.9%)/63 (64.3%)   36 (56.3%)/50 (78.1%)   6 (35.3%)/10 (58.8%)   4 (57.1%)/4 (57.1%)   0 (0.0%)/3 (25.0%)    1 (20.0%)/2 (40.0%)
   Leg pain                       8 (16.7%)/10 (20.8%)    4 (13.3%)/7 (23.3%)     2 (7.4%)/4 (14.8%)      22 (22.4%)/28 (28.6%)   10 (15.6%)/12 (18.8%)   2 (11.8%)/3 (17.6%)    1 (14.3%)/1 (14.3%)   0 (0.0%)/0 (0.0%)     1 (20.0%)/3 (60.0%)
   Gait disturbance               17 (35.4%)/31 (64.6%)   14 (46.7%)/27 (90.6%)   14 (51.9%)/23 (85.2)%   17 (17.3%)/48 (49.0)%   9 (14.1%)/35 (54.7)%    3 (17.6%)/15 (88.2)%   1 (14.3%)/7 (100%)    0 (0.0%)/3 (25.0%)    2 (40.0%)/3 (60.0)%
   Leg paresis                    5 (10.4%)/10 (20.8%)    2 (6.7%)/13 (43.3%)     3 (11.1%)/11 (40.7%)    4 (4.1%)/28 (28.6%)     4 (6.3%)/17 (26.6%)     1 (5.9%)/12 (70.6%)    0 (0.0%)/3 (42.9%)    0 (0.0%)/3 (25.0%)    2 (40.0%)/3 (60.0)%
   BBD                            1 (2.1%)/2 (4.2%)       2 (6.7%)/4 (13.3%)      0 (0.0%)/1 (3.7%)       1 (1.0%)/9 (9.2%)       3 (4.7%)/6 (9.4%)       2 (11.8%)/4 (23.5%)    0 (0.0%)/0 (0.0%)     0 (0.0%)/0 (0.0%)     0 (0.0%)/0 (0.0%)
  Neurologic findings                                                                                                                                                                                                        
   Hyper-PTR                      29 (60.4%)              27 (90.0%)              24 (88.9%)              48 (49.0%)              41 (64.1%)              13 (76.5%)             6 (85.7%)             3 (75.0%)             4 (80.0%)
   Hyper-ATR                      25 (52.1%)              22 (73.3%)              21 (77.8%)              43 (43.9%)              41 (64.1%)              15 (88.2%)             5 (71.4%)             2 (50.0%)             4 (80.0%)
   Positive ankle clonus          16 (33.3%)              20 (66.7%)              20 (74.1%)              28 (28.6%)              24 (37.5%)              9 (52.9%)              3 (42.9%)             0 (0.0%)              4 (80.0%)

ATR = ankle tendon reflex, BBD = bowel bladder disturbance, IET = intradural extramedullary tumor, IMSCT = intramedullary spinal cord tumor, JOA = Japanese Orthopaedic Association, OLF = ossification of the ligamentum flavum, OPLL = ossification of the posterior longitudinal ligament, PTR = patellar tendon reflex, SCH = spinal cord herniation, TDH = thoracic disk herniation, VF = vertebral fracture, VT = vertebral tumor

###### 

Patients\' Demographics for Each Affected Level

  Factor                          Upper                   Middle                  Lower
  ------------------------------- ----------------------- ----------------------- -----------------------
  n                               69                      102                     128
  Sex                                                                             
   Male                           42 (60.9%)              55 (53.9%)              69 (53.9%)
   Female                         27 (39.1%)              47 (46.1%)              59 (46.1%)
  Mean age (yr)                   51.5 ± 15.2 yr          52.2 ± 15.7 yr          53.3 ± 17.1 yr
  Preoperative JOA score          5.4 ± 2.9               4.9 ± 2.6               17.3 ± 35.9 mo
  Mean disease duration (mo)      20.0 ± 39.2 mo          13.6 ± 20.6 mo          6.6 ± 2.5
  Postoperative JOA score         7.4 ± 2.3               6.9 ± 2.1               8.1 ± 2.2
  JOA recovery rate (%)           41.8 ± 27.0             34.1 ± 19.7             39.3 ± 30.7
  Initial/preoperative symptoms                                                   
   Girdle pain                    12 (17.4%)/15 (21.7%)   7 (6.9%)/7 (6.9%)       0 (0.0%)/0 (0.0%)
   Back pain                      21 (30.4%)/28 (40.6%)   24 (23.5%)/26 (25.5%)   4 (3.1%)/4 (3.1%)
   Low back pain                  4 (5.8%)/8 (11.6%)      9 (8.8%)/12 (11.8%)     53 (41.4%)/62 (48.4%)
   Leg numbness                   39 (56.5%)/49 (71.0%)   55 (53.9%)/75 (73.5%)   64 (50.0%)/85 (66.4%)
   Leg pain                       7 (10.1%)/9 (13.0%)     12 (11.8%)/17 (16.7%)   29 (22.7%)/39 (30.5%)
   Gait disturbance               17 (24.6%)/44 (63.8%)   29 (28.4%)/79 (77.5%)   31 (24.2%)/68 (53.1%)
   Leg paresis                    3 (4.3%)/16 (23.2%)     7 (6.9%)/53 (52.0%)     11 (8.6%)/32 (25.0%)
   BBD                            1 (1.4%)/4 (5.8%)       3 (2.9%)/13 (12.7%)     5 (3.9%)/9 (7.0%)
  Neurologic findings                                                             
   Hyper-PTR                      56 (81.2%)              82 (80.4%)              57 (44.5%)
   Hyper-ATR                      51 (73.9%)              74 (72.5%)              53 (41.4%)
   Positive ankle clonus          38 (55.1%)              53 (52.0%)              30 (23.4%)
  Disease                                                                         
   OLF                            7 (10.1%)               3 (2.9%)                38 (29.7%)
   OPLL                           8 (11.6%)               19 (18.6%)              3 (2.3%)
   OPLL + OLF                     5 (7.2%)                18 (17.6%)              3 (2.3%)
   IET                            24 (34.8%)              29 (28.4%)              45 (35.2%)
   IMSCT                          16 (23.2%)              16 (15.7%)              32 (25.0%)
   VT                             7 (10.1%)               7 (6.9%)                3 (2.3%)
   SCH                            2 (2.9%)                5 (4.9%)                0 (0.0%)
   VF                             0 (0.0%)                1 (1.0%)                3 (2.3%)
   TDH                            0 (0.0%)                3 (2.9%)                2 (1.6%)

ATR = ankle tendon reflex, BBD = bowel bladder disturbance, IET = intradural extramedullary tumor, IMSCT = intramedullary spinal cord tumor, JOA = Japanese Orthopaedic Association, OLF = ossification of the ligamentum flavum, OPLL = ossification of the posterior longitudinal ligament, PTR = patellar tendon reflex, SCH = spinal cord herniation, TDH = thoracic disk herniation, VF = vertebral fracture, VT = vertebral tumor

Factors Related to Disease and Affected Level {#s2-3}
---------------------------------------------

Multivariate analyses were performed using the above variables to identify factors that were notably related to disease and affected level. In these analyses, there were significant associations of gait disturbance at initial diagnosis with OPLL (OR, 2.74, 95% CI, 1.16 to 6.50, *P* = 0.022) and OPLL + OLF (OR, 4.18, 95% CI, 1.66 to 10.53, *P* = 0.002) (Table [5](#T5){ref-type="table"} and Figure [1](#F1){ref-type="fig"}); back pain at initial diagnosis with disease at upper (OR, 2.31, 95% CI, 1.14 to 4.66, *P* = 0.02) and middle (OR, 2.22, 95% CI, 1.13 to 4.39, *P* = 0.02) levels; and low back pain with disease at a lower level (OR, 5.12, 95% CI, 2.47 to 10.60, *P* \< 0.01) (Table [6](#T6){ref-type="table"} and Figure [2](#F2){ref-type="fig"}).

###### 

Factors Related to Disease Based on Multiple Logistic Regression Analysis

  Disease                                   Odds Ratio (95% Confidence Interval)   *P*
  ------------ ---------------------------- -------------------------------------- -------
  OPLL         Gait disturbance (initial)   2.74 (1.16-6.50)                       0.022
  OPLL + OLF   Gait disturbance (initial)   4.18 (1.66-10.53)                      0.002

OLF = ossification of the ligamentum flavum, OPLL = ossification of the posterior longitudinal ligament

![Bar graph showing that there were notable associations of gait disturbance at initial diagnosis with OPLL and OPLL + OLF; \#*P* \< 0.01. IET = intradural extramedullary tumor, IMSCT = intramedullary spinal cord tumor, OLF = ossification of the ligamentum flavum, OPLL = ossification of the posterior longitudinal ligament, SCH = spinal cord herniation, TDH = thoracic disk herniation, VF = vertebral fracture, VT = vertebral tumor](jaaos-glob-res-rev-3-0e10.5435c-g001){#F1}

###### 

Factors Related to Affected Level Based on Multiple Logistic Regression Analysis

  Affected level                             Odds Ratio (95% Confidence Interval)   *P*
  ---------------- ------------------------- -------------------------------------- --------
  Upper            Back pain (initial)       2.31 (1.14-4.66)                       0.02
  Middle           Back pain (initial)       2.22 (1.13-4.39)                       0.02
  Lower            Low back pain (initial)   5.12 (2.47-10.60)                      \<0.01

![Bar graph showing that back pain at initial diagnosis with disease at a upper level and low back pain with disease at a lower level were significantly higher than another pain; \#*P* \< 0.01.](jaaos-glob-res-rev-3-0e10.5435c-g002){#F2}

Discussion {#s3}
==========

Thoracic disease with myelopathy is relatively rare, and diagnosis may be delayed.^[@R10]^ The disease can be diagnosed by MRI and CT,^[@R11]^ but criteria are based on limited reports with relatively few patients with thoracic ossification, spondylosis, and disk herniation.^[@R1],[@R2]^ In this study, we included other disorders that are causes of thoracic myelopathy, including spinal tumor, spinal cord tumor, trauma, ossification of the ligament, and SCH, in addition to these diseases, and we identified factors associated with these diseases by comparing symptoms and physical examination findings.

The mean disease duration of IMSCT and SCH tended to be longer than that for other diseases. These diseases are rare,^[@R12][@R13][@R14]^ and the period until surgery may reflect the longer time required for diagnosis. Similarly, the shorter disease durations of VT, VF, and TDH may be linked to their relative ease of diagnosis using radiograph, MRI, and CT.^[@R15],[@R16]^ As in a previous report, OLF occurred at lower levels of the thoracic spine and OPLL and OPLL + OLF at middle levels.^[@R17][@R18][@R19]^ The reasons for the high frequency of OLF at lower thoracic levels include increased mechanical stress where the thoracic vertebrae form the junction between the rigid rib cage and elastic lumbar spine, a direct correlation between increased mobility of the spine and repetitive mild trauma, and high tensile force present in the posterior column.^[@R17]^ Matsumoto et al^[@R20]^ analyzed the surgical outcomes of patients with thoracic OPLL and found an average recovery rate of 36% and reduction of myelopathy immediately after surgery in 12% of patients. As preoperative myelopathy became severe, the JOA recovery rate became worse.

It is generally considered that PTR and ATR were hyper in patients with myelopathy. However, hyper-PTR, hyper-ATR, and positive ankle clonus occurred less frequently at the lower level in this study. The low rate of hyper-PTR, hyper-ATR, and positive ankle clonus may be explained by the involvement of conus and lumbar nerve roots.^[@R21]^ We should be aware of the possibility of lower thoracic diseases without hyper-PTR and hyper-ATR in thoracic myelopathy.

The number of symptoms just before surgery was higher than the number of initial symptoms. Moreover, an increase in the rate of change in preoperative symptoms compared with initial symptoms such as leg numbness, gait disturbance, leg paresis, and BBD was notably higher than that of girdle pain, back pain, and low back pain. In other words, it might mean the finding of increased neurologic compromise with no clear increase in the pain level at the time of surgery compared with the time of the initial diagnosis.

Gait disturbance at initial diagnosis, including leg palsy, leg numbness, posterior column ataxia, and spasticity, was notably associated with OPLL and OPLL + OLF. These are generally severe conditions because of spinal cord compression from the anterior or posterior side, which results in various symptoms. Gait disturbance is a representative symptom for patients with thoracic ossification.^[@R22]^ Back pain at initial diagnosis was notably associated with disease at the upper and middle levels, whereas low back pain was linked to disease at the lower level. The high prevalence of low back pain in patients with lower level disease may be explained by the involvement of the conus, which is a target for treatment of low back pain.^[@R23],[@R24]^ Several case reports have indicated a relationship of back pain with upper and middle level disorders,^[@R25],[@R26]^ and we speculate that a change in pressure in the spinal cord and vertebral column could lead to back pain.

To the best of our knowledge, this is the first report to examine factors related to diseases and levels that result in thoracic myelopathy. It was suggested that the increased neurologic compromise at the time of surgery compared with the time of the initial diagnosis was not associated with the pain level. Gait disturbance at initial diagnosis was associated with OPLL and OPLL + OLF. Back pain at initial diagnosis was associated with disease at the upper and middle levels, whereas low back pain was linked to disease at the lower level.

Conclusion {#s4}
==========

We examined the characteristic factors related to diseases at each level of the thoracic spine that can result in myelopathy, based on symptoms and physical examination findings. We should be aware of the possibility of lower thoracic diseases without hyper-PTR and hyper-ATR in thoracic myelopathy. The increased neurologic compromise at the time of surgery compared with the time of the initial diagnosis was not associated with the pain level. OPLL and OPLL + OLF were characterized by gait disturbance at initial diagnosis. Back pain at initial diagnosis was associated with upper and middle level disease, and low back pain was linked to lower level disease.
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